Compounds having effects on serotonin-related systems
CA 2257962 A1 · Owner: Koch, Daniel James · Inventors: Rocco, Vincent Patrick; Koch, Daniel James
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A series of 1-(4-indolyloxy)-3-(4-hydroxy-4-naphthyl-piperidin-1-yl)propanes are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1A receptor yet , lack mutagenic potential as measured by assays of chromosomal aberration. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 19, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 19, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 19, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.